• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 疫苗:临床终点和心理视角:文献综述。

SARS-CoV-2 vaccines: Clinical endpoints and psychological perspectives: A literature review.

机构信息

Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Guwahati, India; Department of Biomedical Engineering, Indian Institute of Technology Ropar, Rupnagar Punjab, India.

Department of Pharmacology, Jamia Hamdard, New Delhi, India.

出版信息

J Infect Public Health. 2022 May;15(5):515-525. doi: 10.1016/j.jiph.2022.03.017. Epub 2022 Mar 31.

DOI:10.1016/j.jiph.2022.03.017
PMID:35429790
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8969448/
Abstract

BACKGROUND

About 270 million cases have been confirmed, and 5.3 million fatalities Worldwide due to SARS-CoV-2. Several vaccine candidates have entered phase 3 of the clinical trial and are being investigated to provide immunity to the maximum percentage of people. A safe and effective vaccine is required to tackle the current COVID-19 waves. There have been reports that clinical endpoints and psychological parameters are necessary to consider vaccine efficacy. This review examines the clinical endpoints required for a successful SARS-CoV-2 vaccine and the influences of psychological parameters on its efficacy.

METHODS

The main research question was to find out the clinical endpoints that determine the vaccine efficacy? And what kind of psychological parameters affect the vaccine efficacy? The information was taken from several journals, databases, and scientific search engines like Googe scholar, Pubmed, Scopus, Web of Science, Science direct, WHO website, and other various sites. The research studies were searched using keywords; SAR-CoV-2 vaccine efficacy, psychological effect on SARS-CoV-2 vaccine, SARS-CoV-2 vaccine endpoints.

RESULTS

This review has highlighted various clinical endpoints that are the main determinants of clinical vaccine efficacy. Currently, vaccinations are being carried out throughout the world; it is important to investigate the main determinants affecting vaccine efficacy. We have focused on the clinical endpoints and the influence of psychological parameters that affect the vaccine efficacy in clinical settings. The primary endpoints include the risk of infection, symptoms, and severity of COVID-19, while hospitalization length, supplemental oxygen requirement, and mechanical ventilation are secondary endpoints in the clinical endpoints. Some tangential endpoints were also considered, including organ dysfunction, stroke, and MI. Many psychological associated things have influenced the vaccine efficacy, like the lower antibody titers in the vaccinated people. In addition to that, Short- and long-term stress and sleep deprivation were also found to affect the vaccine efficacy.

CONCLUSION

The review summarizes the important clinical endpoints required for a successful vaccine candidate. In addition to primary and secondary endpoints, auxiliary endpoints and the disease burden also play an important role in modulating vaccine efficacy. Moreover, the psychological perspective also influences vaccine efficacy. Effective follow-up of participants should follow to examine the clinical endpoints to reach any conclusion about vaccine efficacy.

摘要

背景

全球范围内已确诊约 2.7 亿例病例,死亡 530 万例。目前已有多个候选疫苗进入临床试验 3 期,旨在为最大比例的人群提供免疫。需要安全有效的疫苗来应对当前的 COVID-19 浪潮。有报道称,临床终点和心理参数是评估疫苗效力所必需的。本综述旨在探讨成功的 SARS-CoV-2 疫苗所需的临床终点以及心理参数对其疗效的影响。

方法

主要研究问题是找出确定疫苗疗效的临床终点?什么样的心理参数会影响疫苗的疗效?信息来自多个期刊、数据库以及谷歌学术、PubMed、Scopus、Web of Science、Science direct、WHO 网站和其他各种网站的科学搜索引擎。使用关键字搜索研究文献;SAR-CoV-2 疫苗效力、SARS-CoV-2 疫苗对心理的影响、SAR-CoV-2 疫苗终点。

结果

本综述突出了作为临床疫苗疗效主要决定因素的各种临床终点。目前,全球正在开展疫苗接种工作;调查影响疫苗疗效的主要决定因素非常重要。我们专注于影响临床环境中疫苗疗效的临床终点和心理参数的影响。主要终点包括感染风险、COVID-19 症状和严重程度,而住院时间、补充氧气需求和机械通气是临床终点中的次要终点。还考虑了一些次要终点,包括器官功能障碍、中风和 MI。许多心理相关因素也影响了疫苗的疗效,例如接种人群中的抗体滴度较低。除此之外,短期和长期的压力和睡眠剥夺也被发现会影响疫苗的疗效。

结论

本综述总结了成功的疫苗候选物所需的重要临床终点。除了主要和次要终点外,辅助终点和疾病负担在调节疫苗疗效方面也起着重要作用。此外,心理观点也会影响疫苗的疗效。应进行有效的随访,以检查临床终点,从而对疫苗的疗效得出任何结论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82ea/8969448/b5c453123499/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82ea/8969448/b5c453123499/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82ea/8969448/b5c453123499/ga1_lrg.jpg

相似文献

1
SARS-CoV-2 vaccines: Clinical endpoints and psychological perspectives: A literature review.SARS-CoV-2 疫苗:临床终点和心理视角:文献综述。
J Infect Public Health. 2022 May;15(5):515-525. doi: 10.1016/j.jiph.2022.03.017. Epub 2022 Mar 31.
2
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.一项评估 SARS-CoV-2 疫苗(灭活,Vero 细胞)有效性和安全性的随机、双盲、安慰剂对照 III 期临床试验:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Apr 13;22(1):276. doi: 10.1186/s13063-021-05180-1.
3
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
4
The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges.SARS-CoV-2 突变与疫苗效力:新机遇与新挑战。
J Infect Public Health. 2022 Feb;15(2):228-240. doi: 10.1016/j.jiph.2021.12.014. Epub 2022 Jan 5.
5
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.COVID-19 疫苗:辉瑞/生物科技和 Moderna 疫苗的生物学、药理学特征和不良反应比较。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877.
6
Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial.在欧洲和拉丁美洲的十个国家评估 CVnCoV SARS-CoV-2 mRNA 疫苗候选物的疗效和安全性(HERALD):一项随机、观察者设盲、安慰剂对照、2b/3 期临床试验。
Lancet Infect Dis. 2022 Mar;22(3):329-340. doi: 10.1016/S1473-3099(21)00677-0. Epub 2021 Nov 23.
7
Coronavirus (SARS-CoV-2): a systematic review for potential vaccines.冠状病毒(SARS-CoV-2):潜在疫苗的系统评价。
Hum Vaccin Immunother. 2022 Dec 31;18(1):1865774. doi: 10.1080/21645515.2020.1865774. Epub 2021 Feb 5.
8
Sufficient Sleep, Time of Vaccination, and Vaccine Efficacy: A Systematic Review of the Current Evidence and a Proposal for COVID-19 Vaccination.充足的睡眠、接种时间和疫苗效力:对当前证据的系统评价及对 COVID-19 疫苗接种的建议。
Yale J Biol Med. 2022 Jun 30;95(2):221-235. eCollection 2022 Jun.
9
Increasing Efficacy of Covid-19 Vaccines by Lifestyle Interventions.通过生活方式干预提高新冠疫苗的效果。
Arch Razi Inst. 2022 Oct 31;77(5):1527-1538. doi: 10.22092/ARI.2021.356491.1854. eCollection 2022 Oct.
10
The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.在英国和美国,针对成年人的 COVID-19 疫苗副作用风险的描述和沟通对疫苗接种意愿的影响:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Sep 6;22(1):592. doi: 10.1186/s13063-021-05484-2.

引用本文的文献

1
Recent advances in the therapeutic applications of selenium nanoparticles.硒纳米粒子治疗应用的最新进展。
Mol Biol Rep. 2024 May 25;51(1):688. doi: 10.1007/s11033-024-09598-z.
2
Exploring the reported adverse effects of COVID-19 vaccines among vaccinated Arab populations: a multi-national survey study.探索接种新冠疫苗的阿拉伯人群中报告的疫苗不良反应:一项跨国调查研究。
Sci Rep. 2024 Feb 27;14(1):4785. doi: 10.1038/s41598-024-54886-0.
3
Infection Prevalence at a Tertiary Hospital in Hail, Saudi Arabia: A Single-Center Study to Identify Strategies to Improve Antibiotic Usage.

本文引用的文献

1
The Impact of COVID-19 On Comorbidities: A Review Of Recent Updates For Combating It.2019冠状病毒病对合并症的影响:抗击该病的最新进展综述
Saudi J Biol Sci. 2022 May;29(5):3586-3599. doi: 10.1016/j.sjbs.2022.02.006. Epub 2022 Feb 10.
2
Clinical Characteristics and Treatment Outcomes of Mild to Moderate COVID-19 Patients at Tertiary Care Hospital, Al Baha, Saudi Arabia: A Single Centre Study.沙特阿拉伯阿巴哈三级护理医院轻度至中度 COVID-19 患者的临床特征和治疗结果:一项单中心研究。
J Infect Public Health. 2022 Mar;15(3):331-337. doi: 10.1016/j.jiph.2022.02.001. Epub 2022 Feb 3.
3
The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges.
沙特阿拉伯海尔一家三级医院的感染患病率:一项旨在确定改善抗生素使用策略的单中心研究
Infect Drug Resist. 2023 Jun 13;16:3719-3728. doi: 10.2147/IDR.S413295. eCollection 2023.
4
Association of SARS-CoV-2 and Polypharmacy with Gut-Lung Axis: From Pathogenesis to Treatment.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)与多种药物联用和肠-肺轴的关联:从发病机制到治疗
ACS Omega. 2022 Sep 16;7(38):33651-33665. doi: 10.1021/acsomega.2c02524. eCollection 2022 Sep 27.
5
Age and Sex Differences Among Mildly Symptomatic and Asymptomatic Patients with Omicron Infection in 2022 in Shanghai, China.2022年中国上海奥密克戎感染轻症和无症状患者的年龄和性别差异
J Multidiscip Healthc. 2022 Aug 31;15:1909-1919. doi: 10.2147/JMDH.S375724. eCollection 2022.
SARS-CoV-2 突变与疫苗效力:新机遇与新挑战。
J Infect Public Health. 2022 Feb;15(2):228-240. doi: 10.1016/j.jiph.2021.12.014. Epub 2022 Jan 5.
4
Active Surveillance of Adverse Events in Healthcare Workers Recipients After Vaccination with COVID-19 BNT162b2 Vaccine (Pfizer-BioNTech, Comirnaty): A Cross-Sectional Study.COVID-19 BNT162b2 疫苗(辉瑞-生物科技,Comirnaty)接种后医护人员不良事件的主动监测:一项横断面研究。
J Community Health. 2022 Apr;47(2):211-225. doi: 10.1007/s10900-021-01039-3. Epub 2021 Oct 9.
5
An overview of SARS-COV-2 epidemiology, mutant variants, vaccines, and management strategies.SARS-CoV-2 流行病学、突变株、疫苗和管理策略概述。
J Infect Public Health. 2021 Oct;14(10):1299-1312. doi: 10.1016/j.jiph.2021.08.014. Epub 2021 Aug 16.
6
Predictive Markers of Immunogenicity and Efficacy for Human Vaccines.人类疫苗免疫原性和效力的预测标志物
Vaccines (Basel). 2021 Jun 1;9(6):579. doi: 10.3390/vaccines9060579.
7
A Coronavirus Outbreak Linked to a Funeral Among a Romani Community in Central Italy.意大利中部一个罗姆人社区中与一场葬礼相关的冠状病毒爆发。
Front Med (Lausanne). 2021 Jun 4;8:617264. doi: 10.3389/fmed.2021.617264. eCollection 2021.
8
Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.住院 COVID-19 患者的凝血病:治疗性抗凝与标准治疗作为对 COVID-19 大流行的快速反应的实用随机对照试验 (RAPID COVID COAG - RAPID 试验):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Mar 10;22(1):202. doi: 10.1186/s13063-021-05076-0.
9
Targets and strategies for vaccine development against SARS-CoV-2.针对 SARS-CoV-2 的疫苗研发的靶点和策略。
Biomed Pharmacother. 2021 May;137:111254. doi: 10.1016/j.biopha.2021.111254. Epub 2021 Jan 28.
10
Immunological surrogate endpoints of COVID-2019 vaccines: the evidence we have versus the evidence we need.COVID-19 疫苗的免疫学替代终点:我们现有的证据与我们所需的证据。
Signal Transduct Target Ther. 2021 Feb 2;6(1):48. doi: 10.1038/s41392-021-00481-y.